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Candida haemulonii is an emerging opportunistic pathogen resistant to most antifungal
drugs currently used in clinical arena. Metal complexes containing 1,10-phenanthroline
(phen) chelating ligands have well-established anti-Candida activity against different
medically relevant species. This study utilized larvae of Galleria mellonella, a widely
used model of in vivo infection, to examine C. haemulonii infection characteristics in
response to different copper(II), manganese(II), and silver(I) chelates containing phen,
which had demonstrated potent anti-C. haemulonii activity in a previous study. The
results showed that C. haemulonii virulence was influenced by inoculum size and
incubation temperature, and the host G. mellonella immune response was triggered
in an inoculum-dependent manner reflected by the number of circulating immune
cells (hemocytes) and observance of larval melanization process. All test chelates
were non-toxic to the host in concentrations up to 10 µg/larva. The complexes also
affected the G. mellonella immune system, affecting the hemocyte number and the
expression of genes encoding antifungal and immune-related peptides (e.g., inducible
metalloproteinase inhibitor protein, transferrin, galiomycin, and gallerimycin). Except
for [Ag2 (3,6,9-tdda)(phen)4 ].EtOH (3,6,9-tddaH2 = 3,6,9-trioxoundecanedioic acid), all
chelates were capable of affecting the fungal burden of infected larvae and the virulence
of C. haemulonii in a dose-dependent manner. This work shows that copper(II),
manganese(II), and silver(I) chelates containing phen with anti-C. haemulonii activity are
capable of (i) inhibiting fungal proliferation during in vivo infection, (ii) priming an immune
response in the G. mellonella host and (iii) affecting C. haemulonii virulence.
Keywords: Candida haemulonii, metal-1,10-phenanthroline chelates, Galleria mellonella, antifungal activity,
immunomodulation
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phagocytic mechanisms between hemocytes and neutrophils,
respectively, identical cell surface receptors such as 3-glucan,
identical signaling cascades of immune deficiency (IMD), c-Jun
N-terminal kinases (JNK) and the Janus kinase/signal transducers
and activators of transcription (JAK-STAT) pathways as well
as nuclear factor-kappa B (NFkB) and IkB kinase transcription
factors modulation by the toll and IMD pathways in the larvae
and by the toll-like receptors and tumor necrosis factor alpha
(TNF-α) in mammals (Browne et al., 2013; Wu et al., 2016).
Moreover, a strong correlation involving microbial virulence and
toxicity of novel antimicrobials between the G. mellonella and
mammalian models has been established (Chamilos et al., 2007;
Wang et al., 2013; Kavanagh and Sheehan, 2018). Therefore,
the G. mellonella model has been widely used to assess the
virulence of microbial pathogens and it was optimized to
increase susceptibility to bacterial and fungal infections for
testing the in vivo activity of antimicrobial agents (Kavanagh
and Sheehan, 2018), which directly influenced our choice for
this model in the current study. Corroborating these findings,
recently, we showed that G. mellonella offered a simple and
feasible model to study C. haemulonii complex virulence and
drug efficacy, in which the first-line antifungals (fluconazole,
amphotericin B, and caspofunfin) were tested with equivalent
therapeutic doses and minimal inhibitory concentrations (MIC)
profile in vitro was correlated with in vivo antifungal efficacy
(Silva et al., 2018).
Herein, we further evaluate the chemotherapeutic
potential of one copper(II)-, seven manganese(II)-, and
three silver(I)-chelates containing the phen ligand toward
the treatment of infections caused by a clinical isolate
of C. haemulonii using the in vivo model, G. mellonella.
We have investigated the virulence of the strain, how
it affects the host immune system, how the chelates
affect the ability of the fungal cells to infect a host
and how the metal-chelates interfere with the larvae
immune response.

INTRODUCTION
Invasive fungal infections have emerged as a significant global
health problem with rising fungemia incidences associated
with excessive morbidity and mortality (Castelli et al., 2014;
Hamdy et al., 2016; Benedict et al., 2017). Candida is the
most common fungal etiologic agent of blood infections
(candidemia) related to vascular catheters, and is associated
with mortality rates of approximately 35% and an impact of
US$ 8 billion to the United States health-care system every
year (World Health Organization, 2014). Invasive candidiasis
affects more than a quarter of a million patients annually
worldwide, and a candidemia incidence of 2–14 per 100,000
inhabitants in population-based studies have been described
(Arendrup and Patterson, 2017). It is also problematic that
recent data have demonstrated a shift on infections toward
non-albicans Candida species that are more resistant to the
available antifungal drugs (Arendrup and Patterson, 2017). This
new and unsettling reality led the WHO to aim at establishing
an operational framework to create a surveillance network
for antifungal resistance as part of the previous established
Global Antimicrobial Resistance Surveillance System (GLASS)
(World Health Organization, 2019). Among such new resistant
emerging opportunistic fungi is the Candida haemulonii complex
(C. haemulonii, Candida haemulonii var. vulnera, and Candida
duobushaemulonii) (Cendejas-Bueno et al., 2012; Kullberg and
Arendrup, 2015). These species are highly resistant to azoles
and polyenes, which are the most commonly prescribed
antifungal drugs. C. haemulonii species are usually sensitive to
echinocandins, a class of antifungal drugs acting on the inhibition
of β-1,3-glucan synthase, which is a key enzyme for integrity of
the fungal cell wall. However, reports of clinical isolates resistant
to micafungin and of therapeutic failure with caspofungin have
been cited (Khan et al., 2007; Kim et al., 2009; Muro et al., 2012).
Such characteristics of the C. haemulonii species complex are a
huge clinical threat and finding new compounds that are effective
against such species is urgently required.
Transition metal chelates containing 1,10-phenantroline
(phen) ligands have been shown to possess anti-Candida
activity against species such as Candida albicans, Candida
glabrata, Candida Tropicalis, and C. krusei (Geraghty et al.,
2000; McCann et al., 2000, 2012; Coyle et al., 2003). These
compounds affect mitochondrial function, reduce cytochrome
b and c synthesis, induce respiratory uncoupling and increase
cell wall permeability of Candida cells (McCann et al., 2004;
Creaven et al., 2007). We have previously demonstrated that
copper(II)-, manganese(II)-, and silver(I)-phen chelates are
highly efficient against the C. haemulonii complex on both
planktonic- and biofilm-growing cells (Gandra et al., 2017).
These previous results stimulated the in vivo studies using
Galleria mellonella larvae described herein, to further elucidate
the hypothesis that such chelates could be potential alternative,
metal-based drugs for treating C. haemulonii infections. The
in vivo G. mellonella model has no ethical issues, is inexpensive
and easy to manipulate and maintain. Most importantly,
the innate immune system of G. mellonella possess several
similarities with humans such as the similar lectin-mediated
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MATERIALS AND METHODS
C. haemulonii Strain
Candida haemulonii (LIP Ch4) isolated in the hospital
service of Universidade Federal Fluminense (obtained from
a fingernail) was used during this study. The antifungal
susceptibility profile of the strain was previously described,
being resistant to azoles and polyenes (Ramos et al.,
2015; Silva et al., 2018). For all assays, fungal cells were
incubated in Sabouraud dextrose culture medium for
48 h at 37◦ C under constant agitation (130 rpm). After
culture, cells were centrifuged at 5,000 × g for 5 min,
washed in sodium phosphate buffer (PBS; NaCl 150 mM,
phosphate buffer 20 mM, pH 7.2) and cells estimated using a
Neubauer chamber.

Galleria mellonella Larvae
The larvae of the greater wax moth G. mellonella were purchased
from Livefoods (Livefoods Direct, United Kingdom) and kept in
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wood shavings at 15◦ C in the dark. Larvae weighing between
0.2 and 0.3 g with no color alterations were selected for all
experiments and used in groups of 10 per experimental parameter
for mortality and 3 for hemocyte extractions (Bergin et al., 2003).

Fungal Infection of Galleria mellonella
Larvae
The infection profile was assessed using a previously described
methodology (Desbois and Coote, 2012; Kavanagh and Sheehan,
2018). C. haemulonii cells were suspended in PBS in the
following concentrations: 5 × 104 , 5 × 105 , 5 × 106 , 5 × 107 ,
and 5 × 108 cells/mL. Using a Myjector syringe (23 gauge;
BD PrecisionGlide), 10 larvae were inoculated through the
last left pro-leg with 20 µl of the cell suspensions, with
final concentrations of 103 , 104 , 105 , 106 , and 107 fungal
cells/larvae, which were injected directly into the hemocoel.
Untouched larvae and larvae inoculated with 20 µL of sterile
PBS were used as controls. The larvae were placed in sterile
petri dishes containing 9 mM filter paper and wood shavings
and incubated at 30 or 37◦ C for up to 9 days, and the mortality
rate was evaluated every 24 h post-infection. For virulence
comparison purposes, a C. albicans strain (ATCC 10231) was
used under the same conditions. Death was determined by
melanization and lack of movement after stimulation with a
needle (Barnoy et al., 2017).

Metal Chelates
The metal chelates used during this study were prepared
following previously published methods (Casey et al., 1994;
McCann et al., 1997, 2004; Devereux et al., 2000; Leon, 2000;
Gandra et al., 2017) and are summarized in Table 1.

Effects of the Metal Chelates on
C. haemulonii: Fungicidal and
Fungistatic Activity
Candida haemulonii was inoculated in a 96-well plate (106
cells/well) containing 200 µL of culture medium and the chelates
with concentrations ranging from 2 to 0.125 mg/L. Plates were
incubated at 37◦ C for 24 h and the contents of each well collected
in Eppendorf tubes and centrifuged at 12,000 g for 2 min. The
supernatant was discarded, the cell pellet re-suspended in PBS
and cellular density was established by direct count in a Neubauer
chamber. The chelate concentration capable of reducing cellular
density by 50% was established by plotting the number of viable
cells vs. the drug concentration log using the Origin Pro 7.5
software. The microdilution protocol described in the document,
M27-A3 published by the Clinical Laboratory Standards Institute,
was used for the fungicidal vs. fungistatic activity analysis (CLSI,
2008). C. haemulonii (106 cells/well) was inoculated into a 96well plate containing the chelates in concentrations ranging
from 0.0625 to 32 mg/L and plates were incubated for 48 h
at 37◦ C. After that, an aliquot of 50 µl from each well with
no visible growth was inoculated into agar Sabouraud plates,
which were incubated for 48 h at 37◦ C. The plates where
visible colonies were present were considered as a fungistatic
chelate concentration, while complete absence of colonies were
designated a fungicidal concentration.

Fungal Burden
Larvae were inoculated with different C. haemulonii
concentrations ranging from 103 to 107 cells per larvae.
The infected models were incubated at 30◦ C, and after 6, 24, and
48 h of infection 3 larvae were randomly selected and washed in
ethanol 70%. After drying, the larvae were cut into small pieces
using a sterile scalpel and added to 15 mL falcon tubes containing
1 mm glass beads (1 g) and 1 mL of PBS + ampicillin (1 mg/L).
The tubes were vortexed for 10 sec, and 100 µL of each sample
was collected and serially diluted. The dilutions were plated
(50 µL) onto Sabouraud plates containing chloramphenicol
(100 mg/L). The plates were incubated during 48 h at 30◦ C and
the number of colony forming units (CFU) were counted.

G. mellonella Immune Response to
Fungal Infection

TABLE 1 | Copper(II) (1), manganese(II) (2-8), and silver(I) (9-11) chelates.
Chelate

Formula

Larvae were inoculated with different C. haemulonii
concentrations ranging from 103 to 107 cells per larvae.
The infected models were incubated at 30◦ C, and after 6, 24,
and 48 h of infection 3 larvae were randomly selected and
the haemolymph extracted (2–3 drops) by piercing the back
of the anterior end with a sterile needle. To prevent clotting
and melanization, the haemolymph was collected into a prechilled Eppendorf and 30 µL were transferred into a 1 in 10
solution of cold PBS containing 0.37% (v/v) 2-mercaptoethanol
(Sigma-Aldrich) (Kelly and Kavanagh, 2011). After gentle
homogenization, 10 µL of the solution were transferred to a
Neubauer chamber and the hemocytes number counted under
a microscope. Three different counts were performed for each
sample and the cell number multiplied by the dilution factor of
the haemolymph (10) and the hemocytometer (50.000) in order
to determine cellular density.

Synthesis references

1

{[Cu(3,6,9-tdda)(phen)2 ].3H2 O.EtOH}n

Gandra et al., 2017

2

[Mn(ph)(phen)(H2 O)2 ]

Devereux et al., 2000
Devereux et al., 2000

3

[Mn(ph)(phen)2 (H2 O)].4H2 O

4

[Mn2 (isoph)2 (phen)3 ].4H2 O

Devereux et al., 2000

5

{[Mn(phen)2 (H2 O)2 ]}2 (isoph)2 (phen).12H2 O

Devereux et al., 2000

6

[Mn(tereph)(phen)2 ].5H2 O

Leon, 2000

7

[Mn2 (oda)(phen)4 (H2 O)2 ][Mn2 (oda)(phen)4
(oda)2 ].4H2 O

Casey et al., 1994
McCann et al., 1997

8

{[Mn(3,6,9-tdda)(phen)2 ].3H2 O.EtOH}n

9

[Ag(phendione)2 ]ClO4

McCann et al., 2004

10

[Ag2 (3,6,9-tdda)(phen)4 ].EtOH

Gandra et al., 2017

11

[Ag(phen)2 ]ClO4

McCann et al., 2004

3,6,9-tddaH2 , 3,6,9-trioxaundecanedioic acid; phH2 , phthalic acid; isophH2 ,
isophthalic acid; terephH2 , terephthalic acid; odaH2 , octanedioic acid; phen,
1,10-phenanthroline; phendione, 1,10-phenanthroline-5,6-dione.
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while the pellet was discarded. The samples were either stored at
−80◦ C or immediately used. To extract the RNA, samples were
thawed and gently inverted and chloroform (Sigma-Aldrich) was
added to the tubes. After 5 min the samples were centrifuged for
15 min at 12,000 g at 4◦ C to separate it into 3 distinct phases. The
upper phase (clear) containing the RNA was carefully transferred
to a separate Eppendorf. Propan-2-ol (Sigma) (0.5 mL) was
added and the tubes were gently inverted and incubated at room
temperature for 10 min and then centrifuged at 4◦ C for 10 min
at 12,000 g. The supernatant was removed and the RNA pellet
was washed once with 1 mL of 75% ethanol (Sigma) and then
re-suspended in 30 µL of 0.1% dietyl pyrocarbonate (DEPC)
treated water. The purity and concentration of the RNA samples
was measured using the MaestroNanoTM spectrophotometer
(MaestroGen, United States). After an initial blank with 0.1%
DEPC treated water, the absorbance ratios (A260/A280 and
A260/A230) of the samples were recorded. The samples were
then stored at −80◦ C.

G. mellonella Larvae Response to
Metal-Chelates
Metal-Chelate Toxicity and Effect on G. mellonella
Immune Response
Each chelate solution was diluted in dimethyl sulfoxide (DMSO)
or sterile water in concentrations of 1,500, 750, 500, 200,
and 100 mg/L. Using a Myjector syringe (23 gauge; BD
PrecisionGlide), groups of 10 larvae were inoculated with
20 µL of the diluted working solutions, resulting in final test
concentrations of 30, 15, 10, 4, and 2 µg/larva. Untouched
larvae, larvae inoculated with DMSO equivalent to the highest
concentration present in the dilutions (2%) and larvae inoculated
with 20 µL of sterile PBS were used as controls. The injected
samples were placed in sterile petri dishes containing 9 mM
filter paper and wood shaves and incubated at 30◦ C for
72 h and mortality rate was evaluated every 24 h. For the
immunomodulation assays, groups of 10 larvae were inoculated
with 15 and 30 µg/larvae of the chelates and incubated for
24 h as previously described. After this period, 3 random larvae
were chosen, the haemolymph extracted and hemocytes density
established as described above (Kelly and Kavanagh, 2011).

Real-Time, One-step quantitative RT-PCR
Real-Time, One-step RT-PCR was performed in triplicate using a
QuantiFast SYBR Green RT-PCR Kit (Qiagen, United Kingdom)
following the manufactures guidelines. The reactions were
carried out in a 25 µL total volume containing 100 ng of total
RNA and 1 µM final concentration for each forward and reverse
primer in a 96-well plate. Each plate contained negative controls
(without RNA or without RT mix). The plates were sealed and
centrifuged at 1,200 g for 2 min before being placed in a 7,500
Fast Real-Time PCR System (Applied Biosystems, Foster City,
CA, United States). The Real-Time cycler conditions included
10 min RT reaction at 50◦ C and 5 min PCR initial activation step
for 5 min at 95◦ C, followed by 40 cycles of denaturation during
10 s at 95◦ C and 30 s of combined annealing/extension at 60◦ C.
After that, melting-curve analysis were performed to confirm RTPCR specificities. The relative expression was calculated using
the 2−11Ct method, and the Ct values of all immune-related
genes analyzed were normalized against the expression of the
S7e reference gene.

Metal-Chelate Influence Over Expression of Relevant
Antimicrobial Peptides
Target genes and primer sequences
Primer sets (Forward and Reverse sequences) for target and
reference genes were obtained from Sigma Genosys. Table 2
indicates the primer sequences for the gene S7e, a housekeeping
gene that encodes the ribosomal protein S7e and the 4 target
genes associated with the G. mellonella immune response, namely
transferrin, IMPI, galiomicin, and Gallerimycin. In the analysis of
each target gene, it was normalized to the reference gene.

RNA extraction of G. mellonella exposed to metal chelates
Groups of 10 larvae were exposed to the highest concentration
in which none of the chelates induced mortality (10 µg/larvae)
by inoculation directly into the larvae haemolymph as previously
described. All workspace and equipment were previously treated
with RNase Away (Molecular Bioproduct). After 24 h, 3 larvae
were randomly chosen and immersed in liquid nitrogen in a
sterile mortar and ground-up with a sterile pestle into a fine
powder. The mortar was allowed to warm for a few minutes and
1 mL of Tri-reagent (Sigma-Aldrich) was added and the resulting
mixture was gently transferred to an Eppendorf. The sample was
allowed to stand for 2 min before being centrifuged at 2,000 g for
2 min and the supernatant was transferred to a new Eppendorf

Metal-Chelates Treatment Effect Over
Fungal Burden on G. mellonella Infected
With C. haemulonii and Pre-treatment
Effect Over Mortality
Groups of 10 larvae of G. mellonella were inoculated with 5 × 105
cells of C. haemulonii per larvae as previously described. After
1 h post-inoculation, the larva were treated with the chelates

TABLE 2 | Forward (F) and reverse (R) sequences of genes analyzed.
Primer name

Oligonucleotides (50 –30 )

S7e F S7e R

ATGTGCCAATGCCCAGTTG GTGGCTAGGCTTGGGAAGAAT

131

Transferrin F Transferrin R

CCCGAAGATGAACGATCAC CGAAAGGCCTAGAACGTTTG

535

IMPI F IMPI R

ATTTGTAACGGTGGACACGA CGCAAATTGGTATGCATGG

409

Galiomicin F Galiomicin R

CCTCTGATTGCAATGCTGAGTG GCTGCCAAGTTAGTCAACAGG

359

Gallerimycin F Gallerimycin R

GAAGATCGCTTTCATAGTCGC TACTCCTGCAGTTAGCAATGC

175

Fragment size [base pair (bp)]

The housekeeping gene S7e was used as reference.
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in different concentrations (5, 2.5, 1.25, and 0.625 µg/larva).
Untouched larvae, larvae inoculated with PBS and larvae infected
with C. haemulonii but not treated were used as a control.
The samples were then incubated at 30◦ C, and the resulting
fungal burden analyzed after 24 and 48 h of infection. For
the fungal burden analysis, 3 larvae were randomly selected
and washed in ethanol (70% v/v). After they had dried up,
the larvae were cut into small pieces using a sterile scalpel
and added to 15 mL falcon tubes containing 1 mm glass
beads (1 g) and 1 mL of PBS + ampicillin (1 mg/L). The
tubes were vortexed for 10 s and samples were diluted up to
100.000×. Diluted samples were plated (50 µL) into Sabouraud
plates containing chloramphenicol (100 mg/L). The plates were
incubated for 48 h at 30◦ C and the number of CFU were
counted (Mesa-Arango et al., 2013). For the pre-treatment
impact over virulence assays, C. haemulonii cells (5 × 106 )
were incubated in Sabouraud broth containing the chelates
in two different sub-inhibitory concentrations (1/2 and 1/4
of the IC50 value) for 24 h at 37◦ C. After the exposition
period, the tubes were centrifuged at 14,000 g for 2 min
and cells were washed twice in PBS, being resuspended in
20 µL of PBS and inoculated into the larvae as previously
described, with mortality being assessed after 24 and 48 h postinfection.

TABLE 3 | IC50 and fungicidal concentration values for C. haemulonii exposed to
metal chelates.
Fungicidala
(mg/L)

{[Cu(3,6,9-tdda)(phen)2 ]3H2 O.EtOH}n (1)

0.52 ± 0.08

8

[Mn(ph)(phen)(H2 O)2 ] (2)

0.96 ± 0.23

8

[Mn(ph)(phen)2 (H2 O)]4H2 O (3)

0.78 ± 0.18

4

[Mn2 (isoph)2 (phen)3 ]4H2 O (4)

0.69 ± 0.01

16

{[Mn(phen)2 (H2 O)2 ]}2 (isoph)2 (phen).12H2 O (5)

1.07 ± 0.24

8

[Mn(tereph)(phen)2 ]5H2 O (6)

0.59 ± 0.10

32

[Mn2 (oda)(phen)4 (H2 O)2 ][Mn2 (oda)
(phen)4 (oda)2 ]4H2 O (7)

0.55 ± 0.03

8

{[Mn(3,6,9-tdda)(phen)2 ]3H2 O.EtOH}n (8)

0.65 ± 0.10

4

[Ag(phendione)2 ]ClO4 (9)

0.77 ± 0.02

2

[Ag2 (3,6,9-tdda)(phen)4 ].EtOH (10)

0.39 ± 0.07

8

[Ag(phen)2 ]ClO4 (11)

0.36 ± 0.08

1

a Values

reflect concentrations at which no cell growth was detected in the wells
after visual inspection and after the sample being plated into sabouraud agar and
incubated for 48 h.

C. haemulonii Virulence to G. mellonella
Larvae infected with C. haemulonii and with C. albicans under
the same conditions and incubated at 30 or 37◦ C were used
in this assay (Figures 1, 2). Larvae infected with 103 –105
fungal cells/larvae had a small mortality rate after 5 days of
incubation, but with no statistical relevance when compared
to the control inoculated only with PBS. The inoculum of
106 cells/larvae of C. albicans induced mortality rates of 28%
after 24 h and 53, 65, 82, and 90% on the following days at
30◦ C. In contrast, the systems incubated at 37◦ C demonstrated
mortality rates of 83, 85, and 95% after 24, 48, and 72 h
post-infection, respectively. At all analysis points, mortality was
statistically significant when compared with the PBS-inoculated
control (p < 0.05, student t-test). The 107 cells/larva inoculum
caused 100% mortality after 24 h at both temperatures. Regarding
C. haemulonii, mortality in larvae infected with 106 cells and
incubated at 30◦ C was observed after 3 days, which gradually
increased and was statistically significant after 8 days (30%
mortality) when compared with the PBS-inoculated control.
Larvae incubated at 37◦ C only demonstrated mortality after
6 days, but with no statistical relevance when compared with
the PBS-inoculated control. When the inoculum was increased
to 107 cells/larvae, animals incubated at 30◦ C had mortality
rates of 82% after 24 h, increasing to 97 and 100% after 48 h
and 72 h, respectively. Systems incubated at 37◦ C had mortality
rates of 13% after 24 h, progressively increasing to 18, 55,
63, 83, and 88% each day. After 9 days, fungal inoculums of
103 to 105 cells/larvae of both species were not capable of
significantly affecting the larvae mortality. C. albicans induced
mortality rates of 98% (106 inoculum) and 100% (107 ) at both
30 and 37◦ C. The C. haemulonii 106 inoculum only induced
statistically relevant mortality at 30◦ C (60%), while the inoculum
of 107 cells/larvae resulted in mortality rates of 100% at 30◦ C
and 88% at 37◦ C. In the control systems (PBS-inoculated),
mortality rates of 30% were observed at 37◦ C and of 12%
at 30◦ C.

Statistical Analysis
All experiments were performed in triplicate, in three
independent experimental sets. Data were analyzed statistically
by means of Student’s t-test using the GraphPad Prism
version 5.00 for Windows, GraphPad Software (La Jolla, CA,
United States). In all analyses, P-values of 0.05 or less were
considered statistically significant.

Ethics Statement
An ethics statement is not necessary. The clinical isolate was
not obtained directly from a patient. The sample was received
anonymized, without the name or any personal information from
the source. No vertebrates or higher vertebrate animals were used
during the study.

RESULTS
Metal-Chelate IC50 Values and
Fungistatic/Fungicidal Activity
The IC50 values of C. haemulonii exposed to the chelates
(Table 3) ranged between 0.36 and 1.07 mg/L. Silver(I) chelates
had better activity in general, with values ranging between
0.36 and 0.77 mg/L, while manganese(II) chelates had IC50
values ranging between 0.55 and 1.07 mg/L. Fungicidal activity
occurred in concentrations ranging from ≥4 to 32 mg/L for
manganese(II), ≥1 to ≥8 for silver(I) chelates, and of ≥8
for the copper(II) chelate. The best fungicidal activity was
observed for the silver(I) chelates 9 and 11. The manganese(II)
chelate, 6, on the other hand, only demonstrated fungicidal
activity at 32 mg/L.
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FIGURE 1 | Evaluation of the virulence of Candida haemulonii and temperature effect over pathogenesis on Galleria mellonella. Candida Haemulonii, and Candida
albicans cells incubated at 37◦ C for 48 h were harvested and inoculated into groups of 10 larvae of G. mellonella in different concentrations (103 –107 cells/larvae).
Infected larvae were incubated at 30 or 37◦ C for up to 9 days and mortality assessed every 24 h. CH 30, C. haemulonii 30◦ C; CA 30, C. albicans 30◦ C; CH 37,
C. haemulonii 37◦ C; CA 37, C. albicans 37◦ C. Larvae inoculated with PBS were used as control. Mortality was determined by lack of movement after stimulation
with a needle and also by melanization.

melanization process was observed in larvae infected with the 107
inoculum (Figure 3E).

Melanization Process in Infected Larvae
No cuticle color alterations were observed in C. haemulonii
larvae inoculate with 103 and 104 cells/larvae (Figures 3A,B).
The 105 inoculum resulted in small-darkened areas around the
needle insertion area (Figure 3C). Larvae infected with 106
cells had more pronounced alterations, with larger darkened
areas observable (Figure 3D). An intense and disseminated
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Fungal Burden Determination in
G. mellonella
Fungal burden in larvae infected with 103 C. haemulonii cells
remained stable between the 6 and 24 h analysis points,
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FIGURE 2 | Comparison of mortality induced by C. albicans and C. haemulonii in G. mellonella. Larvae inoculated with different C. haemulonii cell concentrations
had their mortality assessed after 9 days of incubation at 30 and 37◦ C. Larvae inoculated with C. albicans under the same conditions were used for comparison.
The asterisks denote significant differences compared to the control (∗ P < 0.05). The bars represent the mean ± standard of three independent experiments. CNT,
control (gray bars); CH, C. haemulonii (black bars); CA, C. albicans (white bars).

FIGURE 3 | Melanization process in G. mellonella infected with C. haemulonii. Larvae infected with different C. haemulonii inoculums ((A) 103 , (B) 104 , (C) 105 ,
(D) 106 , and (E) 103 cells/larvae) were incubated for 1 h at 30◦ C and photographed. The arrows indicate melanized areas observable in the images.

inoculum-dependent manner. Infecting animals with 106 cells
resulted in fungal burden progression from 6 h to 24 h (P = 0.01)
and from 24 to 48 h (P = 0.003). Such increases were even
more pronounced with the 107 inoculum, with significant
progression from 6 to 24 h (P = 0.002) and from 24 to
48 h (P = 0.001).

but a significant increase was observed from 24 to 48 h of
incubation (P = 0.04) (Figure 4). It remained stable in all
analysis points in animals infected with the initial inoculums
of 104 and 105 cells/larvae, indicating that the infection was
kept under control by the larvae immune system. Increased
infection progression and fungal burden was detected in an
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FIGURE 4 | Fungal burden in infected G. mellonella. Larvae infected with
different C. haemulonii inoculum sizes were incubated at 30◦ C for up to 48 h.
At 6, 24, and 48 h incubation points, 3 random larvae were collected, sliced
with a scalpel and macerated. The extract was then diluted and plated into
agar sabouraud plates containing chloramphenicol. Plates were incubated for
48 h and the resulting number of colonies were counted. The asterisks denote
significant differences between the 6 and 24 h point (∗ P < 0.05). The diamond
symbol denotes significant differences between the 24 and 48 h point
(P < 0.05). The bars represent the mean ± standard of three independent
experiments.

FIGURE 5 | Galleria mellonella immumodulation induced by C. haemulonii
infection. Larvae were inoculated with different C. haemulonii inoculum sizes
and incubated at 30◦ C. Hemocytes were extracted and counted using a
Neubauer chamber after 6, 24, and 48 h of incubation. The asterisks denote
significant differences compared to the control (∗ P < 0.05). The bars
represent the mean ± standard of three independent experiments.

Immune Modulation Induced by
C. haemulonii Infection

exposed to chelates 3 (101.2 × 106 /mL), 5 (90 × 106 /mL), 7
(138 × 106 /mL), and 8 (149 × 106 /mL) had significantly elevated
hemocyte density. No significant differences were detected with
chelates 2 and 11. Doubling the concentration to 30 µg/larva
resulted in a reduction in hemocytes for chelates 3 (15 × 106 /mL)
and 11 (19.6 × 106 /mL) and an increase with chelate 8
(103 × 106 /mL). Chelates 2, 7, and 10 did not induce significant
alterations, whilst chelates 4, 5, 6, and 9, at 30 µg/larva, negated
all hemocytes. There was a complete absence of hemocytes when
chelate 1 was used at both concentrations. The toxicity profiles
of the chelates could be partially responsible for the hemocyte
density alterations. Chelates used at 30 µg/larva that induced 0%
mortality (7 and 8) induced higher hemocyte density or did not
affect it (11), while the more toxic chelates (9, 6, 10, and 4) led to
a significant reduction in hemocyte production.

Hemocyte count for larvae infected with C. haemulonii indicated
the presence of an inoculum-dependent immune response
(Figure 5). No alterations in animals exposed to 103 cells/larva
were detected during the whole analysis. The highest immune
response was observed with the 104 inoculum, which significantly
increased hemocyte density by 132.13% (6 h), 91.88% (24 h),
and 72.26% (48 h) when compared with the PBS-inoculated
control. The 105 inoculum resulted in increased levels of
hemocytes during the first 48 h, while the 106 and 107 inoculums
increased density after 6 h, followed by a significant drop
as time progressed. Due to high mortality rates, it was not
possible to estimate hemocytes density on larvae infected with
107 cells after 48 h.

Metal-Chelate Toxicity Evaluation Using
G. mellonella Larvae
After 72 h of exposure to the chelates, a dose-dependent toxicity
to G. mellonella was detected. All animals tolerated doses of 2, 4,
and 10 µg/larvae (Table 4), with no mortality observed. Similarly,
chelates 4, 6, 7, 8, 10, and 11, at the concentration of 15 µg/larvae,
induced no mortality, while the remaining chelates resulted in
10% (9), 13.33% (5), 35% (3), 40% (2), and 60% (1) mortality.
Increasing the chelate concentration to 30 µg/larvae resulted in
mortality rates ranging between 80 and 100%, except for chelates
7 (30%), 8 (13.33%), 10 (33.33%), and 11 (20%).

Metal-Chelate Effect on the Expression
of Antimicrobial Peptides in G. mellonella
The expression of the immune related peptide genes transferrin,
IMPI, galiomicin, and gallerimycin in G. mellonella exposed to
the metal-chelates was normalized against the S7e reference
gene (Figure 7). Transferrin and IMPI expression was
significantly affected by the manganese(II) chelates 4, 5,
6, and 8 and silver(I) chelates 9, 10, and 11 (P < 0.05).
Galiomicin expression was increased by the silver(I)
chelate 11, while gallerimycin expression was increased
by the manganese(II) chelates 4 and 6 (P < 0.05). It is
noteworthy that, besides affecting IMPI and transferrin
expression, the manganese(II) chelates 5 and 8 are
capable of increasing hemocyte density in G. mellonella, as
previously described.

Immunomodulation Induced by the
Chelates
Control larvae (not exposed to any chelate) had a median
hemocyte density of 75.8 × 106 cells/mL (Figure 6). At an
administered chelate concentration of 15 µg/larva, animals
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TABLE 4 | Chelate toxicity toward G. mellonella.
Chelate

2 µg (µM)

4 µg (µM)

10 µg (µM)

15 µg (µM)

30 µg (µM)

1

0 ± 0 (2.68)

0 ± 0 (5.36)

0 ± 0 (13.41)

60 ± 14.14 (20.15)

2

0 ± 0 (4.6)

0 ± 0 (9.18)

0 ± 0 (22.97)

40 ± 0 (34.46)

3

0 ± 0 (2.97)

0 ± 0 (5.94)

0 ± 0 (14.86)

35 ± 7.07 (22.30)

4

0 ± 0 (1.90)

0 ± 0 (3.80)

0 ± 0 (9.51)

5

0 ± 0 (1.22)

0 ± 0 (2.44)

0 ± 0 (6.14)

6

0 ± 0 (2.98)

0 ± 0 (5.96

0 ± 0 (14.93)

0 ± 0 (22.40)

7

0 ± 0 (0.81)

0 ± 0 (1.62)

0 ± 0 (4.06)

0 ± 0 (6.10)

30 ± 0 (12.2)

8

0 ± 0 (2.71)

0 ± 0 (5.42)

0 ± 0 (13.59)

0 ± 0 (20.39)

13.33 ± 5.77 (40.78)

9

0 ± 0 (1.66)

0 ± 0 (3.32)

0 ± 0 (8.31)

10 ± 10 (12.47)

10

0 ± 0 (3.52)

0 ± 0 (7.04)

0 ± 0 (17.61)

0 ± 0 (26.42)

11

0 ± 0 (4.65)

0 ± 0 (9.30)

0 ± 0 (23.25)

0 ± 0 (34.88)

0 ± 0 (14.27)
13.33 ± 5.77 (9.21)

100 ± 0 (40.30)
90 ± 0 (68.92)
96.67 ± 5.77 (44.6)
80 ± 0 (28.54)
90 ± 0 (18.42)
85 ± 7.07 (44.8)

95 ± 7.07 (24.94)
33.33 ± 5.77 (52.84)
20 ± 14.14 (68.75)

Values and percentages expressed refers to the% of total mortality in a system containing 10 larvae after 72 h of exposition to the chelates. The values in parenthesis
represents the chelate concentration in micromolar/larvae.

24 h post-infection (Figure 9). All of the other chelates increased
fungal burden or did not affect the number of fungal cells
retrieved, except for compound 9.

Treatment Effect Over Fungal Burden in
Infected Larvae of G. mellonella
Candida haemulonii-infected G. mellonella were treated with the
chelates in different concentrations 1 h post-infection. Analysis,
after 24 h of treatment (Figure 8), indicates that chelates 3
and 8 significantly reduced the number of yeast cells present
in the infected larvae at all of the chelate concentrations used.
Chelate 5 reduced fungal burden at all concentrations except
0.625 µg/larva, while chelates 4 and 7 reduced fungal burden
at the two lowest test concentrations. An increase in the fungal
burden was observed with chelates 4 and 11 at the highest
concentration, with chelate 6 at 5 and 2.5 µg/larva and with
chelate 2 across all administered concentrations. No significant
differences were observed with the other chelates. Analysis at
the 48 h post-treatment time revealed that only chelates 7 and 8
retained the ability to inhibit the fungal proliferation observed at

Pre-treatment Effect Over C. haemulonii
Virulence
Candida haemulonii cells were exposed to sub-inhibitory
concentrations of the chelates (1/2 × IC50 and 1/4 × IC50 ) for
24 h before inoculation of G. mellonella with these fungal cells.
The analysis, 24 h post-infection, revealed that non-treated fungal
cells caused 100% larvae mortality, while some of the chelates
were capable of affecting the fungal virulence (Table 5). For
C. haemulonii pre-treated with 1/2 × IC50 , the manganese(II)
chelates 2, 3, 5, and 6 and silver(I) chelate 11 were the most
effective, reducing mortality rates by 55–100%. Lowering the
concentration of pre-administered chelates to 1/4 × IC50 resulted
in no alterations in virulence with chelates 1 and 7 while the other
chelates reduced mortality by 10–55%. After 48 h of infection by
the pre-treated C. haemulonii cells, larvae mortality rates were
high (75–100%) for all chelates except 3 and 5 (90% reduction
in mortality with 1/2 × IC50 ).

DISCUSSION
The emergence of new opportunistic fungal pathogens that
are resistant to antifungal drugs is a major concern, and the
WHO established a Global Antimicrobial Resistance Surveillance
System (GLASS) to drive regional, national and global actions
against antimicrobial resistance in the future (World Health
Organization, 2019). There are many new antimicrobial resistant
species emerging worldwide which include Candida, and among
them is C. haemulonii, which possesses a reduced susceptibility
profile to the available antifungal drugs (Ramos et al., 2015;
Sanguinetti et al., 2015). New antifungal compounds are urgently
required in order to circumvent this resistance profile. We have
previously demonstrated the antifungal activity of copper(II),
manganese(II), and silver(I) complexes containing phen-type
ligands against the C. haemulonii complex (Gandra et al., 2017).
Based on our previous results we selected one copper (1), seven

FIGURE 6 | Immunomodulation induced by the chelates in G. mellonella. G.
mellonella larvae were exposed to the metal chelates in different
concentrations (15 and 30 µg/larva) during 24 h at 30◦ C. After incubation, 3
larvae were randomly chosen, their hemocytes extracted and the number
estimated. The bars represent the mean ± standard deviation of three
independent experiments. Asterisks indicate significant differences in relation
to the control system (P < 0.05).
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FIGURE 7 | Effect of chelates on antimicrobial peptide expression in G. mellonella. Larvae were inoculated with 10 µg/larva of the chelates and incubated for 24 h at
30◦ C. After that, total RNA was extracted and RT-PCR performed. The genes transferrin, IMPI, galiomycin, and gallerimycin were analyzed and PCR products were
normalized against the housekeeping gene, S7e. The bars represent the mean ± standard deviation of three independent experiments. Asterisks indicate significant
differences in relation to the control system (P < 0.05).

Cryptococcus gattii (Scorzoni et al., 2013; Maurer et al., 2015;
Rossi et al., 2016). However, C. haemulonii had the opposite
temperature profile, with a higher mortality rate in larvae
incubated at 30◦ C. This trend may be explained by examining
the C. haemulonii isolation history, first from the gut of the fish
Haemulon sciurus, and subsequently from dolphin skin and from
seawater (Van Uden and Kolipinski, 1962; Gargeya et al., 1991;
Khan et al., 2007). Curiously, the optimum temperature of the
H. sciurus ranges between 25.5 and 28◦ C, in a median of 27.3◦ C
(Kaschner et al., 2016). Such information could explain why,
although C. haemulonii is capable of causing infections at 37◦ C,
it has a higher virulence at 30◦ C, which could, in part, be the
reason for the low incidence of this species as etiologic agents in
human infections.
An inoculum-dependent fungal burden, hemocyte density and
melanization processes was detected, and these aspects seem to
be interrelated. For instance, while larvae infection with 104
and 105 cells resulted in a stable fungal burden over time, in
larvae infected with 103 cells/larva proliferation occurred. Such
a phenomenon might be associated with the fact that the 103
inoculum induced no increase in hemocytes, thus allowing the
fungal cells to proliferate. Contrarily, the 104 and 105 inoculums
resulted in increased hemocyte density and a small melanization
process (105 ), which might have kept fungal proliferation under
control, since such an increase in circulating hemocytes is

manganese (2–8), and three silver chelates (9–11) for further
analysis using the insect larvae, G. mellonella, a model widely
employed as a first choice for preliminary in vivo antimicrobial
drug testing. Initial analysis revealed that the chelates have
a fungicidal activity at higher concentrations and fungistatic
activity in lower doses, a profile previously described for
antibiotic drugs such as fluconazole, voriconazol and caspofungin
(Meletiadis et al., 2007; Venisse et al., 2008; Domán et al.,
2015; Lee and Lee, 2018). A recent meta-analysis suggests
that fungicidal drugs might have an advantage regarding early
therapeutic success (Kumar et al., 2018), making the fungicidal
properties of the chelates a possible advantageous property.
The current virulence studies using G. mellonella revealed that
fungal inoculum size was directly associated with the infection
outcome and that C. haemulonii was less virulent than C. albicans,
with 10-times more C. haemulonii cells required to obtain
similar mortality rates. This finding corroborates previous data
demonstrating a higher C. albicans virulence to G. mellonella
in comparison with other Candida species (Cotter et al., 2000;
Bergin et al., 2003; Scorzoni et al., 2013). Incubation temperature
also directly impacted on Candida virulence and mortality
induced by the infection. C. albicans was found to be more
virulent at the higher temperature of 37◦ C (compared to 30◦ C),
a feature previously known for this species and other pathogenic
fungi such as Aspergillus terreus, Cryptococcus neoformans, and
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FIGURE 8 | Effect of chelate treatment (24 h) on fungal burden in infected larvae of G. mellonella. Larvae infected with 5 × 105 cells/larva of C. haemulonii were
treated with the chelates 1 h post-infection. The larvae extract was plated into agar sabouraud containing chloramphenicol and the resulting number of colonies
counted. Asterisks indicate significant differences in relation to the control system (P < 0.05).

known to protect G. mellonella against fungal pathogens (Mowlds
et al., 2008). Severe melanization was observed with the 106
and 107 inoculum, which coincided with reduced hemocyte
density. This could be explained by data that suggest that,
although the G. mellonella immune response is primarily through
phagocytosis, when faced with a large number of invading
microorganisms the nodulation/melanization process is mainly
used by the larvae (Dunphy et al., 1986; Wu et al., 2016). Such
an inoculum-dependent strategy adopted by the larvae observed
in our assays was previously described in studies estimating
hemocyte density in larvae inoculated with Aspergillus fumigatus,
C. albicans, and Saccharomyces cerevisiae and in melanization
studies using C. albicans and C. krusei (Bergin et al., 2006;
Mowlds et al., 2010; Fallon et al., 2011a; Scorzoni et al., 2013).
All of the metal-chelates were well tolerated by G. mellonella
in concentrations of up to 500 mg/L (10 µg/larva), but
at 750 mg/L (15 µg/larva) some mortality occurred, which
increased upon raising the concentration of administered chelate.
Regarding the type of metal ion contained in the chelate, the
solitary copper(II) complex (chelate 1) had a high toxicity
profile, while the manganese(II) chelate (8) induced the lowest
mortality rate. In this context, our previous study using A549
cells revealed that copper(II) chelates had very low selectivity
indexes, while manganese(II) chelates demonstrated very high
selectivity indexes (Gandra et al., 2017). This demonstrates
that chelates containing copper(II) ions are more toxic than
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their manganese(II) and silver(I) counterparts toward both
mammalian cells and G. mellonella. It is important to mention
that the MIC values previously established with the chelates for
all species of the C. haemulonii complex ranged between 0.26
and 5.96 mg/L (Gandra et al., 2017), which was much lower than
the highest non-toxic concentration of all chelates (500 mg/L)
observed in the present study.
The chelates, particularly the manganese(II) species (8),
also demonstrated immunomodulation properties, affecting the
hemocyte density and the gene expression of antimicrobial
peptides (AMPs), especially transferrin and IMPI, which are key
components of the larvae immune system and responsible for
eliminating pathogens that have evaded the cellular response
(Bergin et al., 2006). Such characteristics could be useful
for a possible novel antifungal chelate, since previous studies
have demonstrated that antifungal drugs, besides inhibiting
proliferation and killing fungal cells, possess immunomodulatory
properties that confer an additional combat mechanism against
such antimicrobial resistant infections (Mesa-Arango et al.,
2012). For instance, amphotericin B is capable of inducing
different cell lines to produce nitric oxide (NO), prostaglandins
and reactive oxygen intermediates, besides several cytokines
and chemokines. Furthermore, amphotericin B, fluconazole,
voriconazole, micafungin, and caspofungin are all capable of
increasing the antifungal activity of different immune cells
such as macrophages, polymorphonuclear leukocytes (PMN) and
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FIGURE 9 | Forty-eight hours treatment effect over fungal burden in infected larvae of G. mellonella. Larvae infected with 5 × 105 cells/larvae of C. haemulonii and
treated with different chelates concentration 1 h post-infection were macerated, and the extract diluted and plated into agar sabouraud plates containing
chloramphenicol. Asterisks indicate significant differences in relation to the control system (P < 0.05).

chelates are capable of a direct in vivo effect and are not acting
only through a secondary effect, as the immune response induced
in the previous assays.

monocytes (Tohyama et al., 1996; Cenci et al., 1997; Chiller
et al., 2001; Roilides et al., 2002; Choi et al., 2004; Ben-Ami
et al., 2008; Mesa-Arango et al., 2012; Scorzoni et al., 2013;
Fuchs et al., 2016). A similar increase in hemocyte density and
AMPs expression in G. mellonella is induced by the antifungal
drug caspofungin, which confers higher resistance to subsequent
C. albicans infections (Kelly and Kavanagh, 2011). Since such
immunomodulatory effects are another possible mechanism that
aids the host in fighting an infection and are induced by
different antifungal drugs, these immunomodulatory properties
demonstrated by the chelates are an interesting trait.
Fungal burden was reduced by chelates 3, 4, 5, 7, and 8 with
at least one of the concentrations used. Interestingly, all of these
chelates, except the manganese(II) species (4), also induced an
increase in hemocyte density in the larvae. In a previous study
with larvae infected with C. albicans and treated with fluconazole
and fluconazole associated with tetracycline-derived drugs, a
similar reduction in fungal burden was reported (Gu et al.,
2017). However, it is noteworthy that the drug concentrations
used to achieve such an effect were much higher than the
chelate concentrations used in the present study. The same study
reported a gradual increase in the number of CFUs obtained
from infected animals over time, indicating a limited drug
activity, which a similar feature observed in the current study.
Surprisingly, chelate 8 retained most of its anti-proliferation
capacity, with similar numbers of CFUs obtained after 24 and 48 h
of treatment. This result is important as it demonstrates that the
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TABLE 5 | Impact on virulence of Candida haemulonii toward G. mellonella
following pre-exposure of the fungal cells to sub-inhibitory concentrations of the
chelates.
Chelate

Time of infection (hours)
24

Control
Candida haemulonii
Concentration

12

0±0

0±0

85 ± 7.07

100 ± 0

1/2 IC50

1

85 ± 7.07

2

45 ± 7.07

3

5 ± 7.07

4

85 ± 7.07

5

48

0±0

1/4 IC50

1/2 IC50

1/4 IC50

100 ± 0

100 ± 0

100 ± 0

55 ± 7.07
75 ± 21.21
70 ± 0
45 ± 7.07

80 ± 14.14 100 ± 0
10 ± 0

100 ± 0

100 ± 0

100 ± 0

10 ± 14.14 100 ± 0

6

15 ± 7.07

60 ± 0

90 ± 0

100 ± 0

7

65 ± 7.07

100 ± 0

100 ± 0

100 ± 0

8

50 ± 0

60 ± 14.14

9

65 ± 7.07

90 ± 0

10

70 ± 0

11

15 ± 7.07

90 ± 14.14

90 ± 0

100 ± 0

100 ± 0

85 ± 7.07

90 ± 0

100 ± 0

90 ±

75 ± 7.07

100 ± 0
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The increase in fungal burden observed with some chelates
might be due to a reduction in hemocyte density or to
impaired hemocyte activity when the density was not affected.
With the latter scenario, our hypothesis is that the chelates
might be affecting the production of reactive oxygen species
(ROS) by the NADPH oxidase complex, which is essential for
the larvae immune system and hemocytes to fight invading
agents (Browne et al., 2013). To exemplify, it is known that
fumagilin, a toxin produced by A. fumigatus, reduces neutrophil
capacity of phagocyting and killing microorganisms due to
reduced formation of the NADPH oxidase complex (Fallon
et al., 2010). It has also been described that, although no
reduction in G. mellonella or hemocyte viability was observed,
fumagilin induces a reduction in hemocytes oxygen uptake,
which indicates reduced ROS production since this depends on
a sufficient oxygen supply besides a functioning NADPH oxidase
complex. Additionally, fumagilin also reduces the hemocyte
capacity of phagocyting opsonized conidia of A. fumigatus
and opsonized C. albicans cells (Fallon et al., 2010, 2011b).
Neutrophils and hemocytes possesses similarities regarding
oxidative burst, presence of homolog proteins p40phox , p47phox ,
p67phox e gp91phox and similar microorganism elimination
through the NADPH oxidase complex activity. Such information
could indicate that the reduction in the hemocyte immunologic
capacity occurs by a similar mechanism observed in neutrophils,
the non-functionality of the NADPH complex (Fallon et al.,
2011b). Knowing that chelates containing phen and related
ligands are capable of uncoupling mitochondrial respiration
(McCann et al., 2004), our hypothesis is that some of the
present chelates are affecting the formation or activity of
the NADPH oxidase complex, and interfering with the ROS
formation capacity of hemocytes, reducing its phagocytosis and
killing capacity.
Finally, a dramatic reduction in larvae mortality was observed
when C. haemulonii cells were exposed to chelates 2, 3, 5, 6,
8, and 11 prior to infection of G. mellonella larvae. Such an
outcome is known as the post-antifungal effect (PAFE), which is
described as an inhibition of fungal proliferation after a limited
exposure to an antifungal agent (Minguez et al., 1994). Such
an attenuated virulence of C. albicans, Candida Tropicalis, and
Candida kefyr was previously reported for these fungal cells
upon exposure to sub-inhibitory concentrations of amphotericin
B, fluconazole, ketoconazole, and 5-flucitosine, which affected
aspects such as growth rate, susceptibility to PMN leukocytes
and adhesion capacity to buccal epithelial cells (Abu-El Teen
et al., 1989; Minguez et al., 1994, 1997). The capacity of the
metal-chelates to affect C. haemulonii virulence in a similar way
to classical antifungal drugs reinforces the possible potential of
using such compounds as antifungal agents.

In summary, our data indicates that manganese(II) and
silver(I) chelates containing the phen ligand have potent antiC. haemulonii activity and are reasonably non-toxic toward
G. mellonella. Variations in toxicity levels and on the immune
response of larvae exposed to the chelates indicates that chemical
structural differences, even minimal ones, directly impacts over
how the chelates affect the fungal cells and the host, G. mellonella.
The manganese(II) chelate, 8, demonstrated very interesting
characteristics, possessing very good antifungal capacity, low
toxicity, a capacity to induce an immune response and to reduce
the fungal burden on infected animals and also an ability to
affect C. haemulonii virulence. More research is needed in order
to better understand the mechanisms of action of the chelates
and to allow for the development of new compounds that are
more active and less toxic and which could become alternative
therapeutic agents for treating multi-resistant Candida species.
We believe that the present study offers important insights for the
future treatment of antimicrobial resistant pathogens worldwide.
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